Log in

Relevant bibliographies by topics / Tumor necrosis factor / Journal articles

To see the other types of publications on this topic, follow the link: Tumor necrosis factor.

Journal articles on the topic 'Tumor necrosis factor'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Tumor necrosis factor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

KEYSTONE, E. C., and C. F. WARE. "Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies." Journal of Rheumatology Supplement 85 (May 1, 2010): 27–39. http://dx.doi.org/10.3899/jrheum.091463.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chung, Phil-Sang, та Pil-Seob Jeong. "Antitumor effect of Tumor Necrosis Factor-α". Journal of Clinical Otolaryngology Head and Neck Surgery 7, № 1 (1996): 45–55. http://dx.doi.org/10.35420/jcohns.1996.7.1.45.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Inoue, Mamoru, Hidetoshi Inoko, and Kimiyoshi Tsuji. "Tumor necrosis factor." Ensho 12, no. 1 (1992): 21–32. http://dx.doi.org/10.2492/jsir1981.12.21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Old, Lloyd J. "Tumor Necrosis Factor." Scientific American 258, no. 5 (1988): 59–75. http://dx.doi.org/10.1038/scientificamerican0588-59.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wenzel, Richard P., Roger C. Bone, and Michel P. Glauser. "Tumor necrosis factor." Critical Care Medicine 21, Supplement (1993): S414–422. http://dx.doi.org/10.1097/00003246-199310001-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

TRACEY, KEVIN J., and ANTHONY CERAMI. "Tumor necrosis factor." Critical Care Medicine 21, Supplement (1993): S423–435. http://dx.doi.org/10.1097/00003246-199310001-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vilcek, J., and T. H. Lee. "Tumor necrosis factor." Journal of Biological Chemistry 266, no. 12 (1991): 7313–16. http://dx.doi.org/10.1016/s0021-9258(20)89445-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chu, Wen-Ming. "Tumor necrosis factor." Cancer Letters 328, no. 2 (2013): 222–25. http://dx.doi.org/10.1016/j.canlet.2012.10.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Duerrschmid, Clemens, JoAnn Trial, Yanlin Wang, Mark L. Entman, and Sandra B. Haudek. "Tumor Necrosis Factor." Circulation: Heart Failure 8, no. 2 (2015): 352–61. http://dx.doi.org/10.1161/circheartfailure.114.001893.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Varfolomeev, Eugene E., and Avi Ashkenazi. "Tumor Necrosis Factor." Cell 116, no. 4 (2004): 491–97. http://dx.doi.org/10.1016/s0092-8674(04)00166-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Wakefield, Philip E., William D. James, Curt P. Samlaska, and Monte S. Meltzer. "Tumor necrosis factor." Journal of the American Academy of Dermatology 24, no. 5 (1991): 675–85. http://dx.doi.org/10.1016/0190-9622(91)70102-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Lebrec, Hervé, Rafael Ponce, Bradley D. Preston, Jan Iles, Teresa L. Born, and Michele Hooper. "Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk." Current Medical Research and Opinion 31, no. 3 (2015): 557–74. http://dx.doi.org/10.1185/03007995.2015.1011778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Balkwill, Fran. "Tumor necrosis factor or tumor promoting factor?" Cytokine & Growth Factor Reviews 13, no. 2 (2002): 135–41. http://dx.doi.org/10.1016/s1359-6101(01)00020-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Tsutsumi, Yasuo, Shinichi Tsunoda, Yoshihisa Kaneda та ін. "In vivoAnti-tumor Efficacy of Polyethylene Glycol-modified Tumor Necrosis Factor-α against Tumor Necrosis Factor-resistant Tumors". Japanese Journal of Cancer Research 87, № 10 (1996): 1078–85. http://dx.doi.org/10.1111/j.1349-7006.1996.tb03113.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Heffler, Enrico, Mike Berry та Ian D. Pavord. "Tumor Necrosis Factor-α". BioDrugs 21, № 6 (2007): 345–49. http://dx.doi.org/10.2165/00063030-200721060-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Old, L. "Tumor necrosis factor (TNF)." Science 230, no. 4726 (1985): 630–32. http://dx.doi.org/10.1126/science.2413547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Lynch, Joseph P., та Galen B. Toews. "Tumor Necrosis Factor-α". Chest 96, № 3 (1989): 457–59. http://dx.doi.org/10.1378/chest.96.3.457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Wajant, H., K. Pfizenmaier, and P. Scheurich. "Tumor necrosis factor signaling." Cell Death & Differentiation 10, no. 1 (2003): 45–65. http://dx.doi.org/10.1038/sj.cdd.4401189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ray, L. B. "Tumor Necrosis Factor Response." Science Signaling 4, no. 196 (2011): ec301-ec301. http://dx.doi.org/10.1126/scisignal.4196ec301.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

THEODOSSIADIS, PANAGIOTIS G., NIKOLAOS N. MARKOMICHELAKIS, and PETROS P. SFIKAKIS. "TUMOR NECROSIS FACTOR ANTAGONISTS." Retina 27, no. 4 (2007): 399–413. http://dx.doi.org/10.1097/maj.0b013e3180318fbc.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Barone, F. C., B. Arvin, R. F. White та ін. "Tumor Necrosis Factor-α". Stroke 28, № 6 (1997): 1233–44. http://dx.doi.org/10.1161/01.str.28.6.1233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Herrera-Garza, Eduardo H., Sonny J. Stetson, Angela Cubillos-Garzon, Mary T. Vooletich, John A. Farmer та Guillermo Torre-Amione. "Tumor Necrosis Factor-α". Chest 115, № 4 (1999): 1170–74. http://dx.doi.org/10.1378/chest.115.4.1170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Mayhew, Maren S. "Tumor Necrosis Factor Inhibitors." Journal for Nurse Practitioners 5, no. 5 (2009): 376–77. http://dx.doi.org/10.1016/j.nurpra.2009.03.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mazor, Rafi, Osnat Itzhaki, Shifra Sela та ін. "Tumor Necrosis Factor-α". Hypertension 55, № 2 (2010): 353–62. http://dx.doi.org/10.1161/hypertensionaha.109.144154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Rock, Craig S., та Stephen F. Lowry. "Tumor necrosis factor-α". Journal of Surgical Research 51, № 5 (1991): 434–45. http://dx.doi.org/10.1016/0022-4804(91)90146-d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Bozkurt, Biykem, Kesavan Shan, Yukihiro Seta, Hakan Oral, and Douglas L. Mann. "Tumor necrosis factor-? and tumor necrosis factor receptors in human heart failure." Heart Failure Reviews 1, no. 3 (1996): 211–19. http://dx.doi.org/10.1007/bf00127810.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kaji, Keisuke, Rei Katogi, Yoshiaki Azuma, Asuka Naito, Jun-Ichiro Inoue та Akira Kudo. "Tumor Necrosis Factor α-Induced Osteoclastogenesis Requires Tumor Necrosis Factor Receptor-Associated Factor 6". Journal of Bone and Mineral Research 16, № 9 (2001): 1593–99. http://dx.doi.org/10.1359/jbmr.2001.16.9.1593.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Stoelcker, Benjamin, Brigitte Ruhland, Thomas Hehlgans, Horst Bluethmann, Thomas Luther, and Daniela N. Männel. "Tumor Necrosis Factor Induces Tumor Necrosis via Tumor Necrosis Factor Receptor Type 1-Expressing Endothelial Cells of the Tumor Vasculature." American Journal of Pathology 156, no. 4 (2000): 1171–76. http://dx.doi.org/10.1016/s0002-9440(10)64986-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Zhao, Yiling, Fenghua Yang, Wenyuan Li, et al. "miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1." Tumor Biology 39, no. 2 (2017): 101042831769226. http://dx.doi.org/10.1177/1010428317692264.

Full text

Abstract:

Tumor necrosis factor receptor 1 is the main receptor mediating many tumor necrosis factor-alpha–induced cellular events. Some studies have shown that tumor necrosis factor receptor 1 promotes tumorigenesis by activating nuclear factor-kappa B signaling pathway, while other studies have confirmed that tumor necrosis factor receptor 1 plays an inhibitory role in tumors growth by inducing apoptosis in breast cancer. Therefore, the function of tumor necrosis factor receptor 1 in breast cancer requires clarification. In this study, we first found that tumor necrosis factor receptor 1 was significa

APA, Harvard, Vancouver, ISO, and other styles

30

So, Takanori, Seung-Woo Lee, and Michael Croft. "Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity." International Journal of Hematology 83, no. 1 (2006): 1–11. http://dx.doi.org/10.1532/ijh97.05120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rubin, B. Y., S. L. Anderson, S. A. Sullivan, B. D. Williamson, E. A. Carswell, and L. J. Old. "Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor." Journal of Experimental Medicine 164, no. 4 (1986): 1350–55. http://dx.doi.org/10.1084/jem.164.4.1350.

Full text

Abstract:

TNF-resistant lines of L cells can be derived from TNF-sensitive populations by repeated exposure to TNF, and these resistant L cells, in contrast to sensitive L cells and other types of cells, lack demonstrable cell surface receptors for TNF. We have now found that TNF-resistant L cells produce a factor that is cytotoxic for L cells and has the following distinguishing characteristics of mouse TNF: it is a protein of 43 kD, composed of 16 kD subunits, that competes with TNF for receptor binding, induces hemorrhagic necrosis of the TNF-sensitive mouse sarcoma Meth A, has synergistic cytotoxic

APA, Harvard, Vancouver, ISO, and other styles

32

WHERRY, JANICE C., JAMES E. PENNINGTON, and RICHARD P. WENZEL. "Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies." Critical Care Medicine 21, Supplement (1993): S436–440. http://dx.doi.org/10.1097/00003246-199310001-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Bradley, John R., and Jordan S. Pober. "Tumor necrosis factor receptor-associated factors (TRAFs)." Oncogene 20, no. 44 (2001): 6482–91. http://dx.doi.org/10.1038/sj.onc.1204788.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Wang, Xinming, Chunlan Yang, Heinrich Körner, and Chaoliang Ge. "Tumor Necrosis Factor: What Is in a Name?" Cancers 14, no. 21 (2022): 5270. http://dx.doi.org/10.3390/cancers14215270.

Full text

Abstract:

Tumor Necrosis Factor was one of the first cytokines described in the literature as a soluble mediator of cytotoxicity to tumors. Over the years, more extensive research that tried to employ Tumor Necrosis Factor in cancer treatments showed nevertheless that it mainly functioned as a proinflammatory cytokine. However, this did not stop the search for the holy grail of cancer research: A cytokine that could act as a one-stop treatment for solid tumors and lymphomas. This review will summarize the long experimental history of Tumor Necrosis Factor that caused the initial observations of a tumor

APA, Harvard, Vancouver, ISO, and other styles

35

Chollet-Martin, Sylvie. "Tumor Necrosis Factor and Obesity." Annals of Internal Medicine 110, no. 8 (1989): 666. http://dx.doi.org/10.7326/0003-4819-110-8-666_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Seaton, Timothy B. "Tumor Necrosis Factor and Hypermetabolism." Annals of Internal Medicine 112, no. 9 (1990): 715. http://dx.doi.org/10.7326/0003-4819-112-9-715_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

ZHANG, S., H. S. LILLEHOJ, and M. D. RUFF. "Chicken Tumor Necrosis-Like Factor." Poultry Science 74, no. 8 (1995): 1304–10. http://dx.doi.org/10.3382/ps.0741304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Yavaşoğlu, İrfan. "Tumor Necrosis Factor and Splenectomy." Turkish Journal of Hematology 33, no. 2 (2016): 166. http://dx.doi.org/10.4274/tjh.2016.0040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

van der Poll, Tom, and Stephen F. Lowry. "TUMOR NECROSIS FACTOR IN SEPSIS." Shock 3, no. 1 (1995): 1–12. http://dx.doi.org/10.1097/00024382-199503010-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Dixit, Vishva M. "Thrombospondin and tumor necrosis factor." Kidney International 41, no. 3 (1992): 679–82. http://dx.doi.org/10.1038/ki.1992.104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Roubenoff, R. "Tumor necrosis factor and AIDS." American Journal of Clinical Nutrition 61, no. 1 (1995): 161–62. http://dx.doi.org/10.1093/ajcn/61.1.161a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Schütze, S., P. Scheurich, K. Pfizenmaier, and M. Krönke. "Tumor Necrosis Factor Signal Transduction." Journal of Biological Chemistry 264, no. 6 (1989): 3562–67. http://dx.doi.org/10.1016/s0021-9258(18)94102-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Männel, D. N. "Activities of tumor necrosis factor." Journal of Cancer Research and Clinical Oncology 111, S1 (1986): S43. http://dx.doi.org/10.1007/bf02579940.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ziegler, Elizabeth J. "Tumor Necrosis Factor in Humans." New England Journal of Medicine 318, no. 23 (1988): 1533–35. http://dx.doi.org/10.1056/nejm198806093182309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Piguet, Pierre F., Georges E. Grau, and Pierre Vassalli. "Tumor necrosis factor and immunopathology." Immunologic Research 10, no. 2 (1991): 122–40. http://dx.doi.org/10.1007/bf02918160.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Taylor, Peter C. "Anti–tumor necrosis factor therapies." Current Opinion in Rheumatology 13, no. 3 (2001): 164–69. http://dx.doi.org/10.1097/00002281-200105000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

KOBAYASHI, Nobuyuki. "Tumor Necrosis Factor and AIDS." YAKUGAKU ZASSHI 113, no. 1 (1993): 1–18. http://dx.doi.org/10.1248/yakushi1947.113.1_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Lin, Philana Ling, Hillarie L. Plessner, Nikolai N. Voitenok, and JoAnne L. Flynn. "Tumor Necrosis Factor and Tuberculosis." Journal of Investigative Dermatology Symposium Proceedings 12, no. 1 (2007): 22–25. http://dx.doi.org/10.1038/sj.jidsymp.5650027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Munker, R., and H. Ph Koeffler. "Tumor necrosis factor: Recent advances." Klinische Wochenschrift 65, no. 8 (1987): 345–52. http://dx.doi.org/10.1007/bf01745570.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Leroux-Roels, G. "Tumor Necrosis Factor in Sepsis." JAMA: The Journal of the American Medical Association 263, no. 11 (1990): 1494. http://dx.doi.org/10.1001/jama.1990.03440110056022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!